Thrombosis
2 competing products in clinical development for Thrombosis.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor | Daiichi Sankyo | Phase 2 | Completed | 35 |
| CS1-Sodium Valproate | Cereno Scientific | Phase 1 | Completed | 23 |